WHO warns measles elimination is 'distant goal' as cases surge globally

For decades, measles vaccination looked like a triumph. The disease that once killed thousands now kills far fewer—deaths plummeted 88 percent between 2000 and 2024, saving an estimated 58 million lives. But that progress is now reversing, and the World Health Organization is sounding an alarm that measles elimination, once thought within reach, has become a distant goal.

Last year, 59 countries reported major measles outbreaks. That's nearly triple the number that reported them in 2021. What makes this particularly troubling is where the disease is returning: to places that had declared themselves measles-free. Canada recently lost its elimination status. The United States, which achieved that status in 2000, now faces the same risk. This year alone, American health authorities confirmed 1,798 measles cases—the highest number in a quarter-century.

The problem is not the vaccine. Measles vaccine is cheap, highly effective, and has been available for decades. The problem is that fewer children are getting it. Globally, only 84 percent of children received the first dose in 2024, and just 76 percent received the second dose. That leaves 30 million children inadequately protected against what the WHO director-general calls the most contagious virus on Earth. The second dose matters enormously—it boosts effectiveness to 95 percent and provides lasting immunity. Yet three countries still haven't made it standard practice.

The collapse in vaccination rates traces partly to the pandemic. COVID-19 disrupted immunization programs worldwide, and many countries never fully recovered. Vaccination levels remain slightly below pre-pandemic baselines. But the problem runs deeper. Misinformation circulates. Access remains uneven. And crucially, the infrastructure that delivers vaccines—trained health workers, cold chains, transport networks, disease surveillance systems—has deteriorated or never existed in many places. Building and maintaining these systems requires sustained funding, and that funding is shrinking. The WHO warns that deep cuts to the Global Measles and Rubella Laboratory Network, which operates 760 labs that help detect and respond to outbreaks, could widen immunity gaps and trigger new surges.

There have been bright spots. Cape Verde, Seychelles, and Mauritius became the first African countries to achieve measles elimination this year. Twenty-one Pacific island nations did the same. But these victories are exceptions. The WHO official overseeing immunization programs acknowledged that progress toward elimination is "very slow" and that measles deaths remain "inacceptably high" when every death is preventable with an inexpensive vaccine.

The disease functions as a warning system. When measles resurges, it signals gaps in vaccination coverage and inequalities in health access. Those same gaps leave populations vulnerable to other vaccine-preventable diseases like whooping cough and polio. The hardest-hit populations are children in fragile, conflict-affected regions—places where health systems are weakest and need is greatest.

The path forward requires sustained domestic funding and new international partnerships. Without it, the WHO cautions, immunity gaps will widen and new outbreaks will follow. A disease that seemed conquered is returning, not because the tools to stop it have failed, but because the will and resources to deploy them have faltered.